Amy H. Huang/X
Dec 9, 2025, 08:02
Amy H. Huang: Our Work on Bone Health in Myeloma Has Been Recognized with ASH Abstract Achievement Award
Amy H. Huang, Internal Medicine Resident Physician at University of Connecticut, posted on X:
“Excited to share our work at ASH! This is a bi-institutional study (UConn and Yale) on bone health in myeloma that has been recognized with ASH Abstract Achievement Award.
- Delays in dental screening is a major contributor to guideline nonadherence of bone-modifying agent (BMA) prescriptions. Opportunity for QI initiatives to streamline the process.
- Only around 56% of BMA prescriptions were fully concordant with the IMWG guidelines.
- The occurrence of skeletal events were also found to be similar between patients who received more than 5 years of BMA versus less than 5 years. This raises the question of whether prolonged use of BMA really confers benefit and further research is needed.
Managing morbidities is as important as treating the malignancy itself. Sometimes this is what patients care about the most.”
Get the latest from Hemostasis Today.
-
Dec 9, 2025, 23:37Thomas Reiser: Renew Your ISTH Membership for 2025
-
Dec 9, 2025, 10:17Laura Vater: Admitting You Don’t Know Something Actually Helps People Trust You More
-
Dec 9, 2025, 09:06Maria Elisa Mancuso on NXT007 Prophylaxis in People With Haemophilia A
-
Dec 9, 2025, 09:00Cedric Hermans Presenting FRONTIER2 Data on Mim8 in Adolescents and Adults with Haemophilia A
-
Dec 9, 2025, 08:42Muhammad Awidi: IV Iron During Acute Infection Shows Improved Outcomes
-
Dec 9, 2025, 08:35Haseena MS: MAR Oncology and Hematology Invites New Research
-
Dec 9, 2025, 08:26Akshay Kumar Chopra: 3 Years as a Part of KMC Manipal
-
Dec 9, 2025, 08:07William Aird: Understanding Polycythemia
-
Dec 9, 2025, 08:02Raul Cordoba About IV Iron in Hospitalized Patients With Iron-Deficiency Anemia